Marijn Dekkers, Novalis LifeSciences founder and chairman (Martin Meissner/AP Images)
December 10, 2021 10:02 AM EST
Financing

Dekkers-found­ed in­vest­ment firm No­valis Life­Sciences rais­es $300M for sec­ond fund and adds to the team

Paul Schloesser

Associate Editor

Two years ago, life sci­ences VC No­valis Life­Sciences an­nounced that it had raised $85 mil­lion for its first fund, look­ing to in­vest in­to any­where be­tween …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Mer­ck buys in­to PD-1/VEGF space as Sum­mit comes for Keytru­da

Ex­clu­sive: As­cid­i­an CEO Michael Ehlers leaves Ap­ple Tree Part­ners for MPM BioIm­pact

FDA ap­proves PTC’s ul­tra-rare dis­ease gene ther­a­py for broad­er pa­tient pop­u­la­tion than Eu­rope

Met­sera rais­es $215M for stud­ies of GLP-1 and amylin obe­si­ty drugs

GSK makes case for Blenrep's re­turn with new blood can­cer sur­vival da­ta

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times